Free Newsletter
Gene combo dramatically increases risk of Alzheimer's
New work at the Translational Genomics Research Institute in Phoenix has revealed that a copy of the APOE4 gene variant quadruples a person's chances of developing late-onset Alzheimer's. Couple that with the GAB2 variant and the chance of developing the disease rises to 16 times the average risk factor. The scientists believe that the combination of the two spurs the development of one of the proteins that afflicts the brains of people with Alzheimer's. In their work, the scientists screened the DNA of 1400 people, half of whom had the disease.
- here's the report from China Post
ALSO: The latest worldwide estimate of Alzheimer's prevalence shows that 26.6 million people were living with the disease in 2006. That number is expected to quadruple by 2050. Report
Related Articles:
Gene abnormality linked to Alzheimer's. Report
Enzyme essential to preventing Alzheimer's. Report
BRNI discovery raises hopes for Alzheimer's test. Report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceBiotech Research email newsletter for FREE!
Be the first to comment